Erratum: Antibodies against human BLyS and APRIL attenuate EAE development in marmoset monkeys (Journal of Neuroimmune Pharmacology (2012) 7:3 (557-570) DOI: 10.1007/s11481-012-9384-x);Antibodies against human BLyS and APRIL attenuate EAE development in marmoset monkeys

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 3, 2012, Pages 557-570

  Jagessar, S Anwar ^a,b   Heijmans, Nicole ^a   Bauer, Jan ^c   Blezer, Erwin L A ^d   Laman, Jon D ^b,e   Migone, Thi Sau ^f   Devalaraja, Matt N ^f   Hart, Bert A ^a,b,g  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b ErasMS Center for Translational Research into MS   (Netherlands)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f GLAXOSMITHKLINE   (United States)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

B cell Depletion; Cytokines; EAE; Multiple sclerosis; Non human primate

Indexed keywords

APRIL ANTIBODY; APRIL PROTEIN; B CELL ACTIVATING FACTOR; BLYS ANTIBODY; CD20 ANTIGEN; CD40 ANTIGEN; MONOCLONAL ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CALLITHRIX; CONTROLLED STUDY; GENE DELETION; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 84866105902     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9425-5     Document Type: Erratum

References (29)

1. 't Hart BA, Gran B, Weissert R (2011) EAE: imperfect but useful models of multiple sclerosis. Trends Mol Med 17:119-125
2. Bacchetti P, Deeks SG, McCune JM (2011) Breaking free of sample size dogma to perform innovative translational research. Sci Transl Med 3:87ps24
3. Barun B, Bar-Or A (2012) Treatment of multiple sclerosis with Anti-CD20 antibodies. Clin Immunol 142:31-37
4. Boon L, Brok HP, Bauer J, Ortiz-Buijsse A, Schellekens MM, Ramdien-Murli S, Blezer E, van Meurs M, Ceuppens J, de Boer M, 't Hart BA, Laman JD (2001) Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J Immunol 167:2942-2949 (Pubitemid 32768930)
5. Brok HP, Uccelli A, Kerlero De Rosbo N, Bontrop RE, Roccatagliata L, de Groot NG, Capello E, Laman JD, Nicolay K, Mancardi GL, Ben-Nun A, 't Hart BA (2000) Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule. J Immunol 165:1093-1101 (Pubitemid 30484781)
6. Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, Bennett CL (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10:816-824
7. Daridon C, Youinou P, Pers JO (2008) BAFF, APRIL, TWE-PRIL: who's who? Autoimmun Rev 7:267-271 (Pubitemid 351273682)
8. Doxiadis GG, van der Wiel MK, Brok HP, de Groot NG, Otting N, 't Hart BA, 't Hart BA, van Rood JJ, Bontrop RE (2006) Reactivation by exon shuffling of a conserved HLA-DR3-like pseudogene segment in a New World primate species. Proc Natl Acad Sci USA 103:5864-5868
9. Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M, Lees MB, Linington C, Hauser SL (1995) Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 96:2966-2974
10. Halpern WG, Lappin P, Zanardi T, Cai W, Corcoran M, Zhong J, Baker KP (2006) Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects. Toxicol Sci: An official journal of the Society of Toxicology 91:586-599 (Pubitemid 43827311)
11. Jagessar SA, Smith PA, Blezer E, Delarasse C, Pham-Dinh D, Laman JD, Bauer J, Amor S, 't Hart BA (2008) Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets. J Neuropathol Exp Neurol 67:326-340 (Pubitemid 351507488)
12. Jagessar SA, Kap YS, Heijmans N, van Driel N, van Straalen L, Bajramovic JJ, Brok HP, Blezer EL, Bauer J, Laman JD, 't Hart BA (2010) Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant. J Neuropathol Exp Neurol 69:372-385
13. Jagessar SA, Gran B, Heijmans N, Bauer J, Laman JD, 't Hart BA, Constantinescu CS (2012a) Discrepant effects of human interferon-gamma on clinical and immunological disease parameters in a novel marmoset model for multiple sclerosis. J Neuroimmune Pharmacol 7:253-265
14. Jagessar SA, Heijmans N, Blezer EL, Bauer J, Blokhuis JH,Wubben JA, Drijfhout JW, van den Elsen PJ, Laman JD, 't Hart BA (2012b) Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56 peptide in incomplete adjuvant. Eur J Immunol 42:217-227
15. Kap YS, Smith P, Jagessar SA, Remarque E, Blezer E, Strijkers GJ, Laman JD, Hintzen RQ, Bauer J, Brok HP, 't Hart BA (2008) Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells. J Immunol 180:1326-1337
16. Kap YS, van Driel N, Blezer E, Parren PW, Bleeker WK, Laman JD, Craigen JL, 't Hart BA (2010) Late B cell depletion with a human anti-human CD20 IgG1kappa monoclonal antibody halts the development of experimental autoimmune encephalomyelitis in marmosets. J Immunol 185:3990-4003
17. Kap YS, Bauer J, Driel NV, Bleeker WK, Parren PW, Kooi EJ, Geurts JJ, Laman JD, Craigen JL, Blezer E, 't Hart BA (2011) B-cell depletion attenuates white and gray matter pathology in marmoset experimental autoimmune ancephalomyelitis. J Neuropathol Exp Neurol 70:992-1005
18. Kerlero de Rosbo N, Hoffman M, Mendel I, Yust I, Kaye J, Bakimer R, Flechter S, Abramsky O, Milo R, Karni A, Ben-Nun A (1997) Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol 27:3059-3069 (Pubitemid 27478380)
19. Lassmann H, Bruck W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: an overview. Brain Pathol 17:210-218 (Pubitemid 46466140)
20. Laws PM, Warren RB (2011) Ustekinumab for the treatment of psoriasis. Expert Rev Clin Immunol 7:155-164
21. Lopez-Diego RS, Weiner HL (2008) Novel therapeutic strategies for multiple sclerosis-a multifaceted adversary. Nat Rev Drug Discov 7:909-925
22. Miller JP, Stadanlick JE, Cancro MP (2006) Space, selection, and surveillance: setting boundaries with BLyS. J Immunol 176:6405-6410 (Pubitemid 43787821)
23. Moisini I, Davidson A (2009) BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol 158:155-163
24. Pers JO, Daridon C, Bendaoud B, Devauchelle V, Berthou C, Saraux A, Youinou P (2008) B-cell depletion and repopulation in autoimmune diseases. Clin Rev Allergy Immunol 34:50-55
25. Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH (2008) Repeated subcutaneous injections of IL12/ 23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 7:796-804
26. Smith PA, Heijmans N, Ouwerling B, Breij EC, Evans N, van Noort JM, Plomp AC, Delarasse C, 't Hart BA, Pham-Dinh D, Amor S (2005) Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. Eur J Immunol 35:1311-1319 (Pubitemid 40542239)
27. Teeling JL, French RR, Cragg MS, van den Brakel J, Pluyter M, Huang H, Chan C, Parren PW, Hack CE, Dechant M, Valerius T, van de Winkel JG, Glennie MJ (2004) Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas. Blood 104:1793-1800 (Pubitemid 39202289)
28. Villoslada P, Abel K, Heald N, Goertsches R, Hauser SL, Genain CP (2001) Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates. Eur J Immunol 31:2942-2950 (Pubitemid 32994546)
29. Zhang L, Zheng S, Wu H, Wu Y, Liu S, Fan M, Zhang J (2009) Identification of BLyS (B lymphocyte stimulator), a non-myelinassociated protein, as a functional ligand for Nogo-66 receptor. J Neurosci 29:6348-6352